Amneal Pharmaceuticals Inc (AMRX)
6.245
+0.13
(+2.13%)
USD |
NASDAQ |
May 02, 13:33
Amneal Pharmaceuticals Shareholders Equity (Quarterly): 19.78M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 19.78M |
| September 30, 2023 | 330.86M |
| June 30, 2023 | 318.17M |
| March 31, 2023 | 294.41M |
| December 31, 2022 | 298.42M |
| September 30, 2022 | 297.47M |
| June 30, 2022 | 280.33M |
| March 31, 2022 | 391.12M |
| December 31, 2021 | 360.34M |
| September 30, 2021 | 350.51M |
| June 30, 2021 | 346.11M |
| March 31, 2021 | 323.02M |
| Date | Value |
|---|---|
| December 31, 2020 | 303.27M |
| September 30, 2020 | 301.04M |
| June 30, 2020 | 306.00M |
| March 31, 2020 | 318.38M |
| December 31, 2019 | 232.01M |
| September 30, 2019 | 218.00M |
| June 30, 2019 | 459.66M |
| March 31, 2019 | 472.20M |
| December 31, 2018 | 504.75M |
| September 30, 2018 | 501.10M |
| June 30, 2018 | 494.50M |
| December 31, 2017 | -385.74M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
19.78M
Minimum
Dec 2023
459.66M
Maximum
Jun 2019
302.57M
Average
306.00M
Median
Jun 2020
Shareholders Equity (Quarterly) Benchmarks
| Fate Therapeutics Inc | 368.42M |
| Ocular Therapeutix Inc | 91.13M |
| Editas Medicine Inc | 349.10M |
| AnaptysBio Inc | 88.10M |
| Stoke Therapeutics Inc | 159.56M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.473B |
| Total Liabilities (Quarterly) | 3.453B |
| Debt to Equity Ratio | 133.49 |
| Current Ratio | 1.628 |
| Net Debt Paydown Yield | 1.03% |